Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

Clinical trial NCT06257693 · RECRUITING

Trial details

NCT number: NCT06257693
Sponsor: Alessa Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Adenocarcinoma

Start date: 2024-06-21
Primary completion: 2028-12-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.